IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Immune Therapeutics Inc

CUSIP: 45252A107 | 6 institutional holders

Quarters

Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2021

MAI Capital Management12,500
0.0% of portfolio›$0
StyleTurnoverLocationFiled
MAI Capital Management
12,500$00.0%IndexVery LowIndependence, OH2021-05-10